patient
admit
hematolog
ward
westmead
hospit
univers
teach
hospit
sydney
australia
juli
septemb
elig
clinic
screen
cs
test
rv
infect
ward
manag
gener
hematolog
hsct
patient
perform
allogen
autolog
hsct
annual
patient
age
year
approv
studi
grant
sydney
west
area
health
servic
ethic
committe
cs
score
deriv
checklist
featur
cough
fever
last
h
sneez
runni
nose
nasal
stuffi
short
breath
oxygen
satur
room
air
crackl
chest
examin
document
clinician
patient
record
one
point
assign
posit
find
nurs
request
perform
screen
daili
enter
cs
score
log
locat
bedsid
chart
pair
nose
throat
swab
nt
viral
test
recommend
patient
score
screen
tool
pilot
april
hematolog
nurs
educ
research
p
e
f
nurs
educ
senior
nurs
staff
use
screen
tool
sampl
collect
techniqu
transport
swab
laboratori
screen
log
place
patient
bedsid
chart
admiss
clinic
characterist
episod
respiratori
ill
ascertain
prospect
direct
question
patient
caregiv
research
observ
temperatur
oxygen
satur
physic
examin
find
provid
treat
clinician
case
note
laboratori
radiolog
result
electron
hospit
databas
demograph
data
hsct
type
date
retriev
follow
definit
use
upper
respiratori
tract
infect
urti
rhinorrhea
sneez
cough
coryza
without
fever
normal
chest
examin
absenc
pulmonari
infiltr
radiolog
imag
chest
comput
tomographi
viral
urti
urti
detect
rv
urt
secret
collect
nt
lower
respiratori
tract
infect
lrti
pneumonia
fever
hypoxia
oxygen
satur
room
air
pulmonari
infiltr
radiolog
imag
chest
comput
tomographi
viral
lrti
lrti
detect
rv
bronchoalveolar
lavag
bal
specimen
bronchoscop
endotrach
aspir
urt
secret
upper
lower
respiratori
tract
infect
u
lrti
lrti
concurr
rhinorrhea
sneez
coryza
viral
u
lrti
u
lrti
detect
rv
bal
bronchoscop
endotrach
aspir
urt
secret
combin
nt
collect
use
steril
swab
moisten
viral
transport
medium
copan
diagnost
corona
california
usa
bal
perform
patient
adequ
respiratori
reserv
discret
hematolog
respiratori
physician
intub
ventil
patient
frequent
bal
sampl
collect
intub
initi
virolog
test
perform
respiratori
virolog
laboratori
centr
infecti
diseas
microbiolog
laboratori
servic
institut
clinic
patholog
medic
research
westmead
hospit
sampl
process
indirect
immunofluoresc
use
monoclon
antibodi
chemicon
inc
temecula
california
usa
influenza
b
piv
respiratori
syncyti
viru
rsv
adenoviru
adv
human
metapneumoviru
antisera
diagnost
hybrid
athen
ohio
usa
avail
novemb
nt
sampl
bal
sampl
cultur
virus
monkey
kidney
cell
line
human
embryon
lung
fibroblast
cultur
observ
twice
weekli
day
cytopath
effect
test
perform
normal
work
hour
result
avail
day
sampl
reach
laboratori
pm
residu
fluid
clinic
sampl
frozen
aliquot
subsequ
collect
store
transfer
queensland
paediatr
infecti
diseas
laboratori
polymeras
chain
reaction
pcr
piv
influenza
b
rsv
human
metapneumoviru
adv
rhinovirus
coronavirus
polyomavirus
wu
ki
human
bocaviru
number
respiratori
tract
infect
rti
episod
hsct
recipi
determin
review
clinic
data
confirm
valid
cs
score
maximum
possibl
mp
score
calcul
review
clinic
inform
obtain
day
cs
score
log
inform
gather
prospect
mp
score
talli
retrospect
without
knowledg
viral
test
result
statist
analysi
perform
use
spss
version
dagstat
median
report
interquartil
valu
compar
use
wilcoxon
sign
rank
test
test
use
compar
proport
perform
cs
score
mp
score
calcul
use
measur
agreement
diagnost
accuraci
assess
use
sensit
specif
posit
neg
predict
valu
npv
likelihood
ratio
correspond
confid
interv
ci
cs
score
compar
combin
pcr
test
criterion
standard
test
pcr
criterion
standard
report
total
respiratori
specimen
nt
bal
sampl
sputa
collect
studi
period
patient
hsct
gener
hematolog
patient
hsct
recipi
predominantli
male
median
age
first
sampl
year
quartil
quartil
median
nt
collect
hsct
recipi
screen
protocol
assess
nt
specimen
collect
hsct
patient
hematolog
ward
sampl
allogen
recipi
autolog
recipi
specimen
patient
schedul
receiv
hsct
within
day
cs
score
record
concurr
sampl
yield
score
yield
score
score
record
tabl
pcr
perform
nt
sampl
alon
pcr
alon
neither
test
sampl
pcr
perform
sampl
owe
insuffici
residu
sampl
volum
sampl
loss
storag
moder
agreement
cs
mp
score
cohen
p
confirm
valid
cs
score
score
place
patient
categori
trigger
rv
test
sampl
higher
proport
sampl
hsct
recipi
clinic
score
laboratori
confirm
rv
compar
score
score
record
tabl
rv
detect
twice
often
patient
score
score
odd
ratio
ci
median
cs
score
highest
episod
lrti
u
lrti
tabl
episod
sensit
specif
cs
score
sampl
hsct
recipi
use
threshold
respect
tabl
use
threshold
correspond
valu
result
similar
patient
sampl
admiss
hsct
diagnost
accuraci
compar
high
influenzarsv
winter
season
australia
remaind
year
data
shown
probabl
rv
infect
hsct
recipi
calcul
vari
preval
rate
tabl
compar
observ
preval
score
increas
probabl
infect
score
reduc
probabl
correspond
probabl
use
threshold
score
diagnost
accuraci
viral
test
procedur
calcul
respiratori
sampl
hematolog
patient
test
pcr
sampl
sensit
specif
alon
compar
combin
pcr
respect
sensit
compar
pcr
alon
specif
sensit
specif
viru
compar
pcr
alon
shown
tabl
one
rv
detect
either
pcr
sampl
collect
hsct
gener
hematolog
patient
gave
posit
result
pcr
sampl
hsct
recipi
ci
p
total
rv
infect
detect
episod
hsct
recipi
includ
rv
episod
gener
hematolog
patient
includ
rv
nosocomi
acquisit
onset
day
hospit
occur
episod
hsct
recipi
incid
admiss
seven
episod
hsct
recipi
fatal
lrti
principl
caus
death
episod
death
lrti
follow
nosocomi
rv
infect
nt
collect
episod
urti
like
rv
detect
pcr
lrti
episod
respect
ci
episod
lrti
proport
sampl
rv
detect
similar
nt
bal
specimen
respect
follow
introduct
cs
tool
collect
nt
hematolog
patient
increas
year
year
p
first
studi
knowledg
confirm
valid
valu
use
simpl
clinic
score
trigger
microbiolog
test
rv
infect
hematolog
hsct
patient
daili
cs
hsct
recipi
symptom
sign
viral
urti
lrti
recommend
previous
guidelin
sampl
test
perform
develop
cs
tool
shown
use
detect
patient
without
rv
infect
limit
abil
diagnos
infect
tool
benefici
stratifi
approach
test
readili
transmiss
organ
highli
vulner
patient
set
perform
best
exclud
rv
infect
threshold
score
symptom
sign
given
preval
npv
fewer
sampl
collect
threshold
verif
bia
may
skew
result
note
screen
tool
quantifi
number
characterist
rather
gave
weight
specif
symptom
sign
order
detect
varieti
rv
may
differ
clinic
featur
sever
weight
specif
clinic
featur
may
improv
perform
cs
tool
could
assess
studi
likelihood
ratio
score
screen
threshold
correspond
small
potenti
import
chang
probabl
infect
cs
tool
exclud
infect
preval
rate
high
outbreak
set
potenti
preval
test
infect
control
measur
warrant
patient
studi
design
evalu
cs
tool
work
clinic
context
reveal
signific
limit
name
low
complianc
observ
screen
tool
score
record
respiratori
sampl
collect
half
score
exceed
although
major
sampl
taken
without
log
score
nt
sampl
increas
follow
introduct
screen
tool
rv
detect
sampl
without
log
score
episod
rti
compar
viral
detect
sampl
score
may
suggest
cs
perform
score
record
practic
reason
pair
nt
chosen
sampl
diagnost
test
rather
nasopharyng
aspir
npa
npa
obtain
highest
viral
burden
urt
pair
nt
sensit
equival
npa
children
may
case
adult
owe
lower
viral
load
sensit
molecular
method
use
optim
rv
detect
nt
caus
less
pain
npa
children
adult
nt
use
studi
greater
toler
adult
especi
hsct
recipi
may
complic
factor
mucos
particularli
multipl
specimen
collect
patient
addit
benefit
nt
includ
greater
eas
collect
nurs
consequ
earlier
collect
npa
requir
addit
equip
expertis
rv
detect
greater
proport
nt
episod
urti
lrti
urt
specimen
less
sensit
rv
detect
bal
lrti
remain
essenti
consid
bal
absenc
posit
rv
set
base
data
molecular
method
identif
includ
diagnost
algorithm
detect
clinic
import
rv
addit
viral
cultur
note
rv
also
posit
pcr
detect
individu
virus
posit
virus
posit
pcr
superior
perform
pcr
virus
well
known
sensit
symptomat
children
adv
known
insensit
symptomat
children
sampl
current
studi
detect
adult
hsct
recipi
poor
sensit
compar
combin
pcr
viral
cultur
nasal
wash
specimen
document
previous
influenza
sampl
rsv
piv
confirm
result
larger
sampl
pair
nt
specimen
addit
half
posit
specimen
virus
detect
kit
show
import
broaden
panel
rv
test
multiplex
pcr
rv
avail
rel
low
cost
use
depend
laboratori
resourc
practic
diagnost
accuraci
clinic
score
system
viral
test
procedur
implement
studi
guid
infect
control
recommend
rv
infect
hsct
gener
hematolog
unit
recommend
score
infect
control
measur
implement
time
sensit
specif
laboratori
test
undertaken
includ
molecular
test
although
test
potenti
rapid
within
work
day
insensit
henc
infect
control
measur
maintain
pend
result
pcr
howev
rapid
turnaround
time
test
remain
import
guid
treatment
influenza
rsv
summari
simpl
cs
tool
rv
infect
develop
implement
hsct
gener
hematolog
ward
tool
effect
exclud
rv
infect
use
threshold
clinic
symptom
sign
recommend
trigger
sampl
viral
test
recommend
pcr
includ
test
viral
cultur
comprehens
virolog
surveil
